Improving Health, Health Care and Quality of Life

News Releases

Dec 10, 2002

DaVita Appoints Gail S. Wick to National Nursing Leadership Post
Nov 15, 2002

DaVita Inc. Adopts Rights Plan
Nov 12, 2002

DaVita Announces Appointment of Lori S. Richardson Pelliccioni, Chief Compliance Officer
Nov 5, 2002

DaVita Inc. Reports 3rd Quarter 2002 Results
Oct 30, 2002

Webcast Alert: DaVita Inc. Announces Q3 2002 Earnings Conference Call and Strategy Presentation Webcast
Oct 15, 2002

DaVita Schedules Investor Meeting on November 6, 2002
Sep 23, 2002

DaVita Honored by AARP
Aug 1, 2002

DaVita Inc. Reports 2nd Quarter 2002 Results
Jul 25, 2002

Webcast Alert: DaVita Q2 2002 Earnings Conference Call
Jun 17, 2002

DaVita Announces ALJ Decision for Florida Laboratory
Jun 7, 2002

DaVita Announces Continuing Developments Concerning the Company's Florida Laboratory
Jun 6, 2002

DaVita Announces Final Results of Stock Tender Offer
May 30, 2002

DaVita Announces Preliminary Results of Stock Tender Offer
May 15, 2002

DaVita Inc. Revises and Extends Tender Offer for Its Common Shares
May 9, 2002

DaVita Inc. Reports 1st Quarter 2002 Results
May 8, 2002

DaVita Inc. Announces Receipt of OIG Subpoena
May 6, 2002

DaVita Invites You to Join Its First Quarter Conference Call on the Web
May 2, 2002

DaVita Inc. Announces Extension of Expiration Date of the Tender Offer for Its Common Shares
May 2, 2002

DaVita Announces Development Concerning the Company's Florida Laboratory
Apr 29, 2002

Amgen Raises EPOGEN Pricing
Apr 25, 2002

DaVita Announces Closing of Note Tender Offer
Apr 23, 2002

DaVita Revises Purchase Price in Tender Offer and Consent Solicitation for Its 9.25% Senior Subordinated Notes Due 2011
Apr 19, 2002

DaVita Revises Tender Offers and Announces Satisfaction of Financing Condition
Apr 16, 2002

DaVita Sets Purchase Price in Tender Offer and Consent Solicitation For Its 9.25% Senior Subordinated Notes Due 2011
Apr 5, 2002

DaVita Announces Receipt of Requisite Consents for its 9.25% Senior Subordinated Notes Due 2011

Show per page

Contact Investor Relations

For media inquiries, please contact:

Media Kit

Kate Stabrawa
2000 16th Street
Denver, CO 80202
(303) 876-7527